Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation (Forbes)

Forbes:
Collate, which is developing tech to automate paperwork for life science companies, emerges from stealth with a $30M seed led by Redpoint at a $100M+ valuation  —  Surbhi Sarna sold her last startup, nVision Medical, for $275 million.  Now she's leaving a partner role at Y Combinator to launch Collate …